In a variety of organisms, a number of proteins associated with the cortical actin cytoskeleton contain SH3 domains, suggesting that these domains may provide the physical basis for functional interactions among structural and regulatory proteins in the actin cytoskeleton. We 
INTRODUCTION
The dynamic regulation of the membrane actin cytoskeleton is of central importance in processes such as cell locomotion and migration, cell adhesion, endocytosis, and polarized secretion (Kubler and Riezman, 1993; Drubin and Nelson, 1996; Gumbiner, 1996; Lauffenburger and Horwitz, 1996; Mitchison and Cramer, 1996) . Although scores of proteins which bind to actin directly or associate with actin indirectly have been identified (Stossel et al., 1985; Pollard and Coo-* Corresponding author. per, 1986; Sun et al., 1995) , understanding of the functions of these proteins and how they are coordinately regulated is far from complete. In view of the wide range of cellular processes in which actin has been implicated and of the number of signaling pathways that influence the actin cytoskeleton, it is not surprising that an increasingly complex picture of the physical and functional interactions among actin-associated proteins is emerging (Noegel and Luna, 1995; Sullivan and Therkauf, 1995; Ayscough and Drubin, 1996) .
Study of the membrane actin cytoskeleton in Saccharomyces cerevisiae is facilitated by the apparent simplic-ity of the cytoskeleton and by the sophisticated genetic analysis possible in this organism. Yeast homologues of many actin-binding proteins found in other species, including cofilin, fimbrin, tropomyosin, profilin, and a heterodimeric actin filament capping complex (Caplp/Cap2p), have been characterized (reviewed by Welch et al., 1994; Ayscough and Drubin, 1996) . Novel genetic screening procedures have also led to the discovery of other actin-associated proteins first or exclusively in S. cerevisiae. The likelihood that principles which emerge from the study of proteins in this second category will be relevant to organisms other than yeast is supported by the fact that yeast cytoskeletal proteins such as Sla2p, Abplp, and Rvs167p show amino acid sequence similarity with proteins in Caenorhabditis elegans and vertebrates (see below and DIS-CUSSION) .
Features common to some actin-associated proteins in a range of organisms from vertebrates to yeasts are the presence of SH3 domains and/or amino acid sequences similar to known SH3 domain-binding sites. SH3 domains are regions of about 50-60 amino acids which bind to short proline-rich regions of their ligands (see Mayer and Eck, 1995 , and the references therein). Vertebrate actin-associated proteins containing SH3 domains include proteins with structural roles such as fodrin and nebulin (Merilainen et al., 1993; Wang et al., 1996) , unconventional myosins (Bement et al., 1994; Stoffler et al., 1995; Goodson et al., 1996) , kinases and associated molecules (Flynn et al., 1993; Turner and Miller, 1994; Hildebrand et al., 1996) , and other actin-binding proteins such as cortactin (Wu and Parsons, 1993) . In S. cerevisiae, SH3-containing proteins include the actin-associated proteins Abplp (Drubin et al., 1990) , Slalp (Holtzman et al., 1993) , and Rvs167p (Bauer et al., 1993) , as well as Bemlp and the recently identified Boilp and Boi2p, which have roles in the maintenance of normal cellular and cytoskeletal morphology (Chenevert et al., 1992; Bender et al., 1996; Matsui et al., 1996) . A number of yeast proteins implicated in cytoskeletal function, including Abplp, Slalp, Boilp, Boi2p, and Srv2p (Field et al., 1990) , contain proline-rich regions which include amino acid sequences similar to known binding sites for SH3 domains. The presence of SH3 domains and potential SH3 domain-binding sites among proteins that are physically and/or functionally associated with actin suggests that SH3 domains may mediate the formation of specific protein complexes that underlie the complex architecture and regulation of the actin cytoskeleton.
Abplp (actin-binding protein) was first identified by actin filament affinity chromatography and was subsequently shown to localize to the cortical actin cytoskeleton ("actin patches") in vivo (Drubin et al., 1988) . Null mutations in the ABP1 gene do not cause obvious cellular growth or cytoskeletal defects, and the molecular functions of Abplp are not yet fully understood. Abplp shares regions of sequence similarity with Dictyostelium coactosin (de Hostos et al., 1993) and the vertebrate actin-binding protein drebrin (see DISCUSSION) , and the known properties and domain structure of Abplp bear resemblance to vertebrate cortactin (Wu and Parsons, 1993) . Abplp and cortactin both contain a single C-terminal SH3 domain and an N-terminal actin-binding domain. The SH3 domain of Abplp has recently been shown to bind specifically in vitro to a proline-rich segment of the Srv2 protein, and Srv2p, like Abplp, localizes to the cortical actin patches (Freeman et al., 1996) .
Srv2p and its vertebrate homologues have been shown to bind monomeric actin (Gieselmann and Mann, 1992; Freeman et al., 1995) , and Srv2p in budding yeast has been implicated in the transmission of cyclic AMP-(cAMP) mediated signals via the RASI adenylyl cyclase pathway (Fedor-Chaiken et al., 1990; Gerst et al., 1991; Wang et al., 1993) . The possible physical linkage of Abplp to the RAS/adenylyl cyclase pathway via Srv2p suggests that Abplp may function in the control of the actin cytoskeleton in response to varying nutritional conditions or environmental stresses. Several proteins in addition to Srv2p seem likely to have functions closely related to that of Abplp. Like Abplp and Srv2p, Slalp (synthetic lethal-ABP1), Sla2p, and Sac6p (yeast fimbrin) coimmunolocalize in the cortical actin cytoskeleton (Drubin et al., 1988; Adams et al., 1989 ; Lila, Yang, and Drubin, unpublished observations) and were identified in a screen for strong genetic enhancers of an ABP1 null mutation (synthetic lethals; Holtzman et al., 1993) . Rvsl67p interacts with actin in the yeast two-hybrid system (Amberg et al., 1995) , and has functions important for sporulation and viability under adverse growth conditions (Bauer et al., 1993) . Rvs167p and Slalp also contain one and three SH3 domains, respectively, suggesting that they too may interact physically with other cytoskeletally associated proteins.
Important tasks are to determine what physical interactions occur among actin-associated proteins in vivo and to determine the functions of these interactions by examining the phenotypic effects of mutations which disrupt them. Here, we report the results of genetic, phenotypic, and immunocytological analysis of the Abplp/Srv2p SH3 domain-mediated interaction in vivo. We demonstrate that the SH3 domain of Abplp mediates the cytoskeletal subcellular localization of Srv2p, but that this function of Abpl is genetically distinct from another function(s) of the protein. Table 1 . Standard growth and sporulation media were used and are described by Rose et al. (1990) . Medium used for URA3 plasmid counterselection (Boeke et al., 1987) (Baudin et al., 1993) . Forward primer 5'-ttt cgt aat tga gta ggc caa gtt gca acc gtg tga aat cga ttg tac tga gag tgc acc-3' and reverse primer 5'-act gtg cgt cgt cct tga aat ctg tga cca tag aca cgg gag tgc ggt att tca cac cgc-3' were used with plasmid pRS306 (Sikorski and Hieter, 1989) (Sambrook et al., 1989) . PCR (Innis et al., 1990) 
Plasmids
The following plasmids were used: pNF275: YCp5O vector (Rose et al., 1987) ; a 10-kb genomic fragment carrying SRV2 cloned as an Sau3A partial digest fragment of S. cerevisiae strain SP1 genomic DNA in the BamHI site of the vector (obtained from N. Freeman and J. Field, University of Pennsylvania, Philadelphia, PA).
pTL102: 1.3-kb SRV2-coding sequence PstI/EcoRI fragment cloned in a KS+ Bluescript vector.
pSRV2-1: pRS315-based (Sikorski and Hieter, 1989) plasmid with 3.4-kb SRV2-containing HindlIl fragment from pNF275 cloned into pRS315. Isolate "a" 5' end is closest to the SacI site of the vector, isolate "b" is in opposite orientation.
pDD210: pRS316 vector, otherwise identical to pSRV2-Ib. pSRV2-2: pSRV2-1 derivative with sequences encoding amino acids 354-358 deleted. Constructed by M13 oligonucleotide-directed mutagenesis (Sambrook et al., 1989 ) using pSRV2-la-derived single-stranded DNA template and primer SRV8 (5'-gta aat ccg gta aaa agc cat caa cat tga aa-3').
pSRV2-3: pSRV2-1 derivative in which sequences encoding the Abplp SH3 domain-binding site (Srv2p amino acids 352-360, ... SGPPPRPKK... ) have been altered to encode an amino acid sequence which matches a consensus chicken cSrc SH3 domain-binding site (RGLPPLPRF). Two-step PCR construction strategy: 5' PCR product-pSRV2-lb template using forward primer BS1 (5'-cga gga atg ttg cgt cag gag cac-3') and reverse primer SRV4 (5'-tgg caa tgg tgg tag acc cct ttt act tcc tgt -3'). 3' PCR product-pSRV2-Ia template using forward primer SRV3 (5'-ggt cta cca cca ttg cca aga ttt cca tca aca ttg-3') and reverse primer BS1. Products were mixed and a 3.5-kb product amplified using primer BS1. Product was cloned as HindIll fragment into pRS315.
pSRV2-4: pSRV2-1 derivative, sequences encoding amino acids 267-285 deleted. Two-step PCR construction strategy: 5' PCR product-pTL102 template, forward primer BS1, reverse primer SRV9 (5'-gac gga agc aga tga agt agc acc tgt att-3'), 3' PCR productpSRV2-1b template, forward primer SRV10 (5'-gct act tca tct gct tcc gtc ttt gaa atc tc-3'), reverse primer SRV2 (5'-cgc cga att ccc tac caa ttc ctt tct agg-3'). MATa/a ura3-52/ura3-52 leu2-3,112/leu2-3,112 his3A2001+lys2-801aml+trpl-1/trpl-1 abpl::LEU2/+rvsl67::TRP1I+ MATa/a ura3-52/ura3-52 leu2-3,112/leu2-3,112 his3A200/+lys2-801amI+ trpl-1ltrpl-1 att cgc atg cta gta agt gga ggg cac tag acc-3') was cloned as BamHI/ EcoRI fragment into pGEX3X. pGSLA1-2: pGEX3X (Pharmacia) derivative. Directs expression of Slalp amino acids 74-131 (SH3 domain 2) as GST fusion in E. coli. PCR product from reaction using forward primer SLA7 (5'-gcg gga tcc cat ggg taa gag cca ttt atg-3'); reverse primer SLA8 (5'-cgc cgg atc cgc atg cta att ctc tgg ttc gac gta-3') was cloned as BamHI/EcoRI fragment into pGEX3X. pGSLA1-3: pGEX3X (Pharmacia) derivative. Directs expression of Slalp amino acids 358-414 (SH3 domain 3) as GST fusion in E. coli. PCR product from reaction using forward primer SLA9 (5'-cgc gga tcc cat ggg gta ttg ttc aat atg ac-3'); reverse primer SLA10 (5'-cgc pABP1-Al: pABP1+-based plasmid, encodes truncated Abplp missing amino acids 536-592. PCR product 1 from reaction using pABP1-1 template, forward primer ABP1 (5'-cga gga agt ttg cgt cag gag cac-3'); reverse primer ABP2 (5'-gct gca tgc taa gga ttt tcc ttt ggc-3') was digested with XbaI + SphI. PCR product 2 from reaction using pABP1-1 template, forward primer ABP3 (5'-gtg cat gcg ggc aac tag aat cac acg-3'); reverse primer BS1 was digested with ApaI + SphI. Restricted PCR products were combined with a gel-purified pABP1 + vector fragment from ApaI/XbaI partial digest and ligated.
pTL5: pABP1 + derivative, contains engineered unique NcoI and SphI restriction sites in place of SH3 domain-coding sequences to allow for heterologous SH3 domain substitution. PCR product from reaction using pABP1-1 template, forward primer ABP1; reverse primer ABP9 (5'-gga tca tag cat gct gtg gcc cat gga ttt tcc-3') was digested with XbaI and SphI and cloned into XbaI/SphI sites of a gel-purified vector fragment from pABP1-2 partial digest. pABP1-Src: pTL5 derivative, contains chicken cSrc SH3 domain amino acid 86-141 coding sequences. PCR product from reaction using cloned chicken cSrc plasmid DNA template, forward primer DH7 (5'-gca cca tgg ttc gtg gct ctc tac gac-3'); reverse primer SRC1 (5'-ctg cgg ccg cat gct agt ctg agg gcg cga cat ag-3') was cloned as NcoI/SphI fragment into a gel-purified vector fragment of NcoI/ SphI-digested pTL5.
pA14S: pTL5 derivative, contains chimeric SH3 domain sequences from Abplp and cSrc domains. Two-step PCR construction strategy: 5' PCR product-pABP1 + template, forward primer ABP1, reverse primer A14S-R (5'-cgt tct cct ttc ttg aag gac agt tcg tta tct tct gc-3'). 3' PCR product-chicken cSrc plasmid template, forward primer A14S-F (5'-tgt cct tca aga aag gag aac g-3'), reverse primer SRC1(5'-ctg cgg ccg cat gct agt ctg agg gcg cga cat ag-3'). Products were mixed, and a 340-bp product was amplified with forward primer ABP1, reverse primer SRC1. Product digested with NcoI + SphI and cloned into pTL5.
pS7A14S: pA14S derivative. PCR product from reaction with pA14S template, forward primer S7A-F (5'-cct ttt agg tac caa gca ccg tga tat act aat gct gcg ac-3'); reverse primer SRC1 was digested with NcoI + SphI and cloned into pTL5.
Immunofluorescence Microscopy
Yeast cultures were grown in SD medium to OD600 of 0.1-0.2 and processed for immunofluorescence as described (Pringle et al., 1989 (Pringle et al., , 1991 . Srv2p localization was achieved using affinity-purified rabbit polyclonal antiserum JF155 raised against full-length Srv2p (gift from Dr. J. Field, University of Pennsylvania). Rabbit polyclonal anti-Abplp antibodies were affinity purified as described (Harlow and Lane, 1988a) using an affinity matrix of 1 ml of swollen cyanogen bromide-Sepharose beads (Pharmacia), to which 2 mg of a GST protein fusion to Abplp amino acids 12-592 had been coupled. Antibodies were eluted from the matrix with 4.5 M MgCl, dialyzed into phosphate-buffered saline plus 30% glycerol, and stored at -20°C. For actin double-labeling experiments, affinity-purified antiAbplp or Srv2p sera at a 1:50 dilution and a guinea pig anti-yeast actin serum (gift from D. Botstein) at a 1:1000 dilution were used. Secondary antibodies were used at a 1:1000 dilution and were rhodamine-conjugated goat anti-rabbit IgG and fluorescein-conjugated goat anti-guinea pig IgG for double-label experiments, and fluorescein-conjugated goat anti-rabbit IgG for single label experiments (Cappel/Organon Teknika, Malvern PA). Slides were viewed and photographed using a Zeiss Axiophot microscope.
E. coli Whole-Cell Extract Production
Recombinant protein expression plasmids were propogated in E. coli strain HB101. Cells were grown in LB medium with 75 ,ug/ml ampicillin at 37°C to OD6. of 0.2. Recombinant protein expression was induced by addition of isopropyl-thio-f3-D-galactopyranoside (Sigma, St. Louis MO) to 0.1 mM and further incubation for 4 h. Cells (1 ml) were then centrifuged and resuspended in 150 ,ul of 50 mM sodium phosphate (pH 7.5)/150 mM NaCl. Twice concentrated SDS-polyacrylamide gel sample buffer (150 ,ul) was added, and the samples were heated for 5 min in boiling water. Samples of 5 .lI were run per lane on SDS-7% polyacrylamide gels. Proteins were transferred to nitrocellulose membranes as described (Harlow and Lane, 1988b) .
SH3 Domain Probes
SH3 domain fusions to GST were purified by glutathione agarose (Sigma) affinity as described (Ausubel, 1990) . Purified protein was exchanged into 0.1 M sodium borate (pH 8.8) by gel filtration and biotinylated by adding 60 ,ug of biotinamidocaproate succinimide ester (Sigma) per mg of protein and incubating for 4 h at room temperature. NH4C1 (100 ,ul, 1 M) was added per mg of protein, and the labeled probe exchanged into phosphate-buffered saline (pH 7.5) plus 10% glycerol. Aliquots were frozen in liquid nitrogen and stored at -20°. Probing of blots of candidate ligands was performed as described (Cicchetti et al., 1992) . Probes were allowed to bind for Vol. 8, February 1997 4 h at 4°C and used at a concentration of 1 ,Lg/ml. Detection was accomplished by a 1-h incubation at 4°C with a 1:5000 dilution of alkaline phosphatase-conjugated streptavidin (Boeringer Mannheim), followed by washing and addition of 5-bromo-4-chloro-3-indolyl-phosphate and nitroblue tetrazolium as recommended by the supplier (Promega, Madison WI).
Amino Acid Similarity Comparisons
Amino acid sequence similarities between Abplp and drebrins were identified using the BLAST algorithim (Altschul et al., 1990 ) made available by the National Center for Biotechnology BLAST server (http://www.ncbi.nlm.nih.gov/BLAST/). An amino acid query missing the SH3 domain was submitted against the GenBank nonredundant protein sequence database using the PAM250 amino acid substitution matrix. Optimal alignment of the Abplp and rat drebrin A (National Center for Biotechnology identifier gi/297821) sequences was performed using the FASTA-based (Pearson and Lipman, 1988) (Cicchetti et al., 1992 analysis. Although the actin cytoskeleton is not noticeably perturbed by ABP1 gene deletion (Drubin et al., 1988) , a difference in Srv2p fluorescence staining is apparent in abpl deletion strains as compared with wild type (Figure 2 ). The apparent loss of cortical actin patch association of Srv2p in abpl mutants is a reproducible effect in several different strain backgrounds. Several experiments demonstrated that loss of Srv2p localization is a specific consequence of disruption of the ABP1 gene. First, the subcellular localizations of other cortical patch-associated proteins including actin, cofilin, and Slalp are not noticeably affected by the abpl null mutation. Second, disruption of the RVS167 (Figure 2) , SLA1, SLA2, or SAC6 genes does not result in loss of Srv2p cortical association. Abplp was also found to localize to cortical actin patches in an apparently normal manner in SAC6, SLA1, SLA2, SRV2, and RVS167 deleted strains. We conclude that the normal localization and/or stable association of Srv2p with cortical actin patch structures requires Abplp.
If the association of Srv2p with the actin patches is dependent on direct interaction with the Abplp SH3 domain, then mutant versions of Srv2p which lack the binding site for the Abplp SH3 domain would also be expected to be deficient in cortical patch association. (residues 337-376) which contains one amino acid motif (KSGPPPRPKK) that is similar to known SH3 domain-binding peptides (Freeman et al., 1996) . Mutant versions of Srv2p containing deletions of large regions of the protein encompassing the above site had been shown to be deficient in actin patch association. These mutant proteins, however, fail to fully complement the morphological and cytoskeletal defects associated with srv2 null mutations (Freeman et al., 1996) , limiting the interpretation of the subcellular localization experiments. We therefore sought to engineer mutations in SRV2 that specifically abolish Abplp SH3 domain binding and to examine the consequences of these mutations on Srv2p subcellular localization and on Srv2p function (see below). To examine mutant Srv2 proteins without interference from the wild-type protein, it was first necessary to disrupt the SRV2 gene in a strain of the S288C background used in our laboratory. The disruption inserts the HIS3 auxotrophic marker gene in the place of nucleotides -3 to 797 relative to the first base of the start codon for SRV2. This gene disruption (referred to here as srv2A2) differs slightly from those generated previously which leave coding sequences for the first 76 amino acids intact. Results of tetrad analysis of a diploid strain heterozygous for the disruption are shown in Figure 3A . Previous phenotypic characterizations of srv2 disruption phenotypes have included failure to grow on rich media (Fedor-Chaiken et al., 1990; Field et al., 1990 ). We do not observe this phenotype for the srv2A2 disruption ( Figure 3A ; see DIS-CUSSION). HIS3+ segregants do show other phenotypes similar to those described for previous srv2 gene disruptions such as a swollen, rounded cell morphology and poor growth at 37°C, and often yield slightly smaller colonies than their his3 counterparts. No Srv2p could be detected in srv2A2 cell extracts by immunoblot analysis.
Mutations affecting the Srv2p SH3 domain-binding site were introduced into a plasmid bearing a genomic DNA fragment containing the SRV2 gene (pSRV2-1). One mutation (in pSRV2-2) is expected to eliminate SH3 domain binding as it deletes Srv2p amino acids 354-358, which include the proline residues thought to be essential features of all SH3 domain-binding sites (Mayer and Eck 1995) . A second mutation (in pSRV2-3) changes the binding site such that the predicted amino acid sequence matches a consensus sequence for peptides which bind to the cSrc SH3 domain (Yu et al., 1994) . Here, the Srv2p sequence has been changed from ... KSGPPPRPKK... to ... KRGLPPLPRF... , to match the peptide consensus of RXLPPLPR0 (0, any hydrophobic amino acid).
To verify that the srv2 mutations have the intended effect on SH3 domain binding in vitro, bacterial GST fusion proteins to the 40-amino acid region of Srv2p containing the wild-type or mutant SH3 domain-binding sites were produced. Binding of bacterially produced GST fusions to the Abplp and cSrc SH3 domains was assayed in a blot overlay assay. The results of these studies are shown in Figure 3B . The wild-type Srv2p SH3 domain-binding site is bound specifically by the Abplp, but not the cSrc SH3 probe. As expected, deletion of critical prolines in the binding site results in no detectable binding above background by either SH3 probe, whereas mutating the binding site to match the cSrc-binding consensus results in preferential binding by the cSrc SH3 probe.
The effect of the SH3 domain-binding site mutations on cortical localization of the mutant Srv2 proteins is shown in Figure 3C . As Gerst et al., 1991) .
To judge whether the effects of the Srv2p mutations described above are restricted to defects in SH3 domain binding (as opposed to the mutations having more global effects on Srv2p), we determined the ability of the mutant proteins to complement growth and morphological defects associated with SRV2 gene disruption. Strain DDY1004, bearing the srv2A2 chromosomal disruption and a control vector plasmid grows with a doubling time of approximately 4 h at 30°C in media selective for the plasmid auxotrophic marker, whereas an isogenic wild-type strain with the same vector plasmid (DDY1003) grows with a doubling time of 2.7 h. Plasmid pSRV2-1, containing the wildtype SRV2 gene, and plasmid pSRV2-2, containing the SH3 domain-binding site deletion, were introduced into a strain bearing the srv2A2 disruption. These strains (DDY1005 and DDY1006) were found to grow with doubling times of 2.5 and 2.6 h, respectively. Plasmids pSRV2-2 and pSRV2-3 (containing the c-Src SH3-binding consensus region in place of the Abpl (Gerst et al., 1991; Mintzer and Field, 1994; Freeman et al., 1995) . Null mutations in SRV2 cause phenotypic effects not seen in abpl null mutants; therefore, Srv2p must have functions that are independent of Abplp. Nonetheless, the physical association of Abplp and Srv2p suggests that the two proteins participate in at least one common function. We wished to determine whether all functions of Abplp require interaction with Srv2p or whether Abplp performs any functions independent of Srv2p. If all functions of Abplp involve binding to Srv2p, then mutations that specifically disrupt SH3 domain-mediated binding should phenotypically mimic null mutations in ABP1. To date, no readily assayed primary phenotypes have been described for abpl mutations, but one notable characteristic of abpl null mutations is "synthetic lethality" in combination with certain other mutations. Cells carrying mutations in the SAC6, SLAI, or SLA2 genes are viable at 25°C, but any of these mutations in combination with an abpl null mutation is lethal (Holtzman et al., 1993) .
We first determined whether the Abplp SH3 domain has a critical function in ABPI-dependent mutant backgrounds by examining the behaviors of abpl mutations targeted to the SH3 domain in strains carrying mutations in SAC6, SLAI, or SLA2. To accomplish this, we constructed strains which contain a mutation in one of these three genes as well as a null mutation in ABP1 (Aabpl). These ABP1-dependent strains are viable due to the presence of a wild-type copy of ABP1 on a plasmid marked with the URA3 auxotrophic marker gene. The above strains allowed us to test the function of ABP1 mutants in a "plasmid shuffle" assay. In this assay, strains are transformed with the mutant abpl plasmids bearing the HIS3 selectable marker, and grown on medium which selects for HIS3 but not URA3 function. Yeast cells containing a functional HIS3-marked version of ABP1 will remain viable upon loss of the URA3 marked plasmid, whereas those bearing a nonfunctional mutant do not. This can be monitored by assaying growth on medium containing 5-FOA, which selects against cells which harbor a wild-type URA3 gene (Boeke et al., 1987) .
Plasmid-borne versions of ABP1 in which the SH3 domain-coding sequence is deleted (pABP1A1) or is replaced by the cSrc SH3 domain (pABP1-Src) were constructed and tested for function in the plasmid shuffle assay. Figure 4 shows the results of this analysis. Neither of the above plasmids can functionally substitute for the wild-type ABP1 gene, demonstrating that the Abplp SH3 domain is required for the viability of ABP1-dependent strains. As an additional test of whether the specific loss of SH3 domain function can explain the behaviors of the above mutations, an additional Abplp SH3 domain-targeted alteration was constructed.
The S7A14S SH3 is a chimeric domain comprised of cSrc SH3 domain amino acid sequences with the exception of those in positions 8-14 ( Figure 4B ), which are their Abplp counterparts. Based on an extensive body of structural information for the cSrc and other SH3 domains, the substituted region is known to correspond to a highly variable specificity determining region of SH3 domains often referred to as the RT Src loop (Noble et al., 1993) . The S7A14S alteration is expected to result in a change in ligand specificity of the parent cSrc SH3 toward that of the Abplp SH3 domain. The in vitro ligand specificity of the S7A14S domain demonstrated in Figure 4C shows that this is indeed the case (compare with Figure 3B ), although some binding specificity for the cSrc SH3 ligand is retained.
The pS7A14S-encoded mutant protein contains just seven amino acids that differ from the protein produced by pABP1-Src, yet Figure 4A shows Figure 4A ), the results suggest that Abplp SH3 domain ligand specificity is of central importance to Abplp function in these genetic backgrounds. Because the Abplp SH3 domain mediates the association of Srv2p with cortical actin patches, we expected that the ability of an abpl mutant allele to localize Srv2p to cortical patches would correlate with the capacity of the allele to function in the plasmid shuffle assay. Figure 5 , however, shows that this is not the case. Although the abplS7A14s allele functions almost as well as wild type in ABP1 -dependent mutant backgrounds, Srv2p does not show obvious association with cortical actin patches in strains carrying this mutation. Srv2p is also delocalized in strains carrying the abplSrc allele.
The results of analysis of ABP1 SH3-targeted mutations suggest that SH3 domain ligand specificity is a central aspect of the Abplp function required in sac6, slal, and sla2 mutant backgrounds, but also suggest that this function is distinct from the function of Abplp in mediating the cytoskeletal localization of Srv2p. These results are consistent with the possibility that the SH3 domain of Abplp is capable of binding to a ligand in addition to Srv2p (see DISCUSSION). Even though all of the Abplp mutant proteins we examined are capable of normal cortical actin patch localization, we cannot rule out the possibility that the failure of some abpl mutations to support the viability of ABP1-dependent strains is due to unintended effects of the mutations on functions of Abplp which are not functions of the SH3 domain per se.
In any case, results of the analysis of the abplS7A14S allele above suggest that a function of Abplp required for viability in ABP1-dependent genetic backgrounds is separate from the function of Abplp in mediating Srv2p subcellular localization. This predicts that srv2 mutations which eliminate binding to the Abplp SH3 domain should also have negligible effects on strains carrying mutations in SLAI, SLA2, or SAC6. We first determined whether wild-type Srv2p is required for the viability of slal, sla2, or sac6 mutants, or is required in strains carrying mutations in genes for other actinassociated proteins. Figure 6 shows the results of tetrad analysis on strains doubly heterozygous for the srv2A2 disruption and marked gene disruptions in the ABP1, SLA1, SLA2, RVS167, and SAC6 genes. To determine the effects of mutations that specifically affect the Srv2p SH3 domain-binding site in strains carrying mutations in SLA2, SAC6, and RVS167, we constructed strains which contain a mutation in one of these three genes as well as the srv2A2 disruption. These SRV2-dependent strains are viable due to the presence of SRV2+ on a plasmid and allowed us to test the function of a battery of srv2 site-directed and deletion mutants in a plasmid shuffle assay similar to that shown in Figure 4A . The results of this analysis are shown in Figure 7 . Plasmids pSRV2-2 and pSRV2-3, which contain the Abplp SH3 domain-binding site mutations, are capable of supporting the viability of strains containing mutations in RVS167, SAC6, or SLA2. Strains harboring these plasmids are indistinguishable from their counterparts carrying wild-type SRV2 (pSRV2-1) in terms of Figure 6 . Effects of combining an SRV2 null mutation with null mutations in genes encoding other actin-associated proteins. 
and DDY1019 (right) bear a chromosomal disruption in the SRV2 gene and the additional mutation labeled that confers SRV2 growth dependence. Each strain originally carried a wild-type copy of SRV2 on a URA3 marked plasmid (pDD210). Strains were transformed with the indicated SRV2 derivative plasmids (marked with the LEU2 gene) and grown for 5 d at 250C on media selective for the LEU2 but not the URA3 marker. Strains were then replica plated onto 5-FOA medium to select against cells harboring the URA3+ SRV2+ plasmid, and growth after 4 d at 250C was photographed.
growth rates and morphologies when grown in rich media after 5-fluoroorotic acid counterselection of the URA3+ SRV2+ plasmid. Thus, the binding site for the Abplp SH3 domain in Srv2p is not required for the vegetative growth of any of the strains in which SRV2 is essential. In addition, growth rates and morphologies of slal/srv2 double mutant strains transformed with either pSRV2-1, pSRV2-2, or pSRV2-3 are indistinguishable. It is unlikely that strong phenotypic effects (e.g., synthetic lethality) of the srv2 mutations are being masked by selection for elevated plasmid copy number, since even significant overexpression of the SRV2 gene from a strong constitutive promoter on a high copy number plasmid (pADH-CAP; Gerst et al. 1991) does not suppress the synthetic lethality of abpllslal, abpl/sla2, or abpllsac6 double mutant combinations in a plasmid shuffle assay.
In addition to the Abplp SH3-binding site, Srv2p contains one prominent proline-rich amino acid motif spanning amino acids 267-285 which could conceivably function as a cryptic binding site for the Abplp SH3 domain or as a binding site for another SH3 domain-containing protein. To test whether this region of Srv2p is required in SRV2-dependent strains, mutants were constructed which delete the coding sequences for amino acids 267-285 (pSRV2-4) or which delete this region in combination with deletion of coding sequences for the Abplp SH3-binding site amino acids [354] [355] [356] [357] [358] . These srv2 mutants are also capable of functioning in the place of wildtype SRV2 in the plasmid shuffle assay (Figure 7) . Further deletion analysis of SRV2 identified larger regions of the gene which are required for viability of the SRV2-dependent strains, but plasmids carrying these srv2 deletions (pSRV2-6, pSRV2-7; Figure 7 ) only partially rescue the slow growth and morphological defects of the srv2A2 disruption; therefore, it is unclear whether the inability of these plasmids to support the viability of SRV2-dependent strains is due to loss of a specific functional site in the Srv2 protein or is due to a general diminution of Srv2p function.
The above experiments show that srv2 mutations which affect binding to the Abplp SH3 domain cause no obvious phenotypic effects even in genetic backgrounds (sac6, rvsl67, slal, or sla2) in which ABP1 and/or SRV2 are required for viability. We conclude that the Srv2p-binding function of Abplp is separate from another function(s) of Abplp which is required for the viability of ABP1-dependent mutant strains. We also show that neither proline-rich region in Srv2p is required in SRV2-dependent genetic backgrounds. We conclude that the essential functions of Srv2p here are unlikely to involve binding by SH3 domain-containing proteins, and must reside in other regions of Srv2p such as the actin-binding or adenylyl cyclasebinding domains.
Mutations in RVS167 and ABP1 Show Similar Phenotypes and Genetic Interactions
Because the Rvs167p SH3 domain binds to a site in Abplp in vitro (Figure 1) , we wished to determine whether the functions of Rvs167p and Abplp in vivo are closely related. As mentioned previously, abpl mutants do not display the obvious growth or morphological abnormalities associated with mutations in some other components of the actin cytoskeleton. Abpl mutant cells are indistinguishable from wild type for a number of properties which we and others have assessed, including growth rates and morphology at temperatures from 14 to 37°C (Drubin et al., 1988) , mating projection formation (Read et al., 1992) , and the kinetics of bud emergence after arrest of the cell cycle by mating pheromone or nutrient deprivation. Loss of function mutations in RVS167 also have only subtle effects on cells growing in rich medium, but cause a number of phenotypes which are apparent in poor growth media. These include rapid loss of viability under starvation conditions or in medium containing sodium chloride, poor growth on media containing nonfermentable carbon sources, and failure of diploid mutant cells to undergo sporulation when starved (Bauer et al., 1993; Desfarges et al., 1993; Munn et al., 1995) .
To determine whether Abplp and Rvs167p are likely to participate in related functions, we examined the behavior of abpl mutant strains in light of the known defects of rvsl67 mutants. The results presented in Table 2A show that AabpllAabpl diploids undergo sporulation more than threefold less efficiently than their wild-type counterparts. This phenotype might result from perturbation of processes that involve either binding partner of Abplp (Srv2p or Rvs167p). Srv2p has been implicated in adenylyl cyclase pathway signaling, and activation of this pathway, like the RVS167 mutation, can result in reduced sporulation efficiency (reviewed Broach, 1991 (Lew and Reed, 1995) . We speculate that the effect of ABP1 mutation on cell viability may result from a loss of cortical integrity, since mutant cultures contained greater numbers of cells that appeared to have undergone lysis or that appeared darkened when viewed by phase-contrast microscopy. The growth rates and viability of srv2A2 mutant cells containing either SRV2+ on a plasmid (pSRV2-1) or SRV2 missing the Abplp SH3 domain-binding site (pSRV2-2) were indistinguishable when cells were grown in medium containing sodium chloride or glycerol, indicating that the effects of abpl mutation under these conditions are not due to loss of the Srv2p-binding function of Abplp.
To further explore the possibility that Abplp and Rvsl67p function in concert, we determined whether Rvs167p is required for the phenotypic effects of Abplp overexpression. Overexpression of ABP1 from a high copy number plasmid in wild-type cells results in a poor cell growth coupled with abnormal cell morphology (Drubin et al., 1988) . Figure 8B shows that in rvsl67 null mutant cells, Abplp overexpression has Vol. 8, February 1997 A B Figure 8 . As an additional test of the relatedness of Abplp and Rvs167p function, we determined whether an rvsl67 null mutation is synthetically lethal in combination with disruptions of the ABP1, SLA1, SLA2, and SAC6 genes. Figure 8C shows that unlike null mutations in SRV2 or any other cytoskeletal gene tested to date, the Arvsl67 mutation is synthetically lethal in combination with disruptions of all three of the genes that display synthetic lethality in combination with abpl mutations. The Arvsl67 mutation does not display negative growth synergism in combination with the Aabpl disruption itself. These observations are consistent with a model in which Rvs167p and Abplp participate in a common function that is dispensable under standard growth conditions but is essential for viability when slal, sla2, or sac6 mutations are present. DISCUSSION Even in a relatively simple cell type such as budding yeast, the functioning of the actin cytoskeleton is mechanistically complex, requiring coordination of the activities of many proteins. The complex yet specific network of interactions among mutations in the genes encoding actin-associated proteins ( Figure 9A ) suggests that the activities of proteins in the cortical patch structures are highly integrated. A thorough understanding of the domain structures, physical interactions, and subcellular localizations of actin-asso-ciated proteins, as well as thorough genetic characterizations of mutations in the genes encoding them may all be required to illuminate the specific molecular processes which occur at the actin patch sites.
The work presented here furthers understanding of the physical and functional interactions of Abplp with other actin-associated proteins ( Figure 9B ). Abplp is capable of binding to Srv2p via its SH3 domain and can also associate with Rvs167p by virtue of a site in Abplp that is bound by the Rvs167p SH3 domain (Figure 1 ; Freeman et al., 1996) . Phenotypic analysis of mutations that affect Abplp, Rvs167p, and Srv2p shows that all three proteins function in cellular responses to adverse or changing environmental conditions, but also provides insight into the nature of the unique contribution that each protein makes to the integrated functioning of the actin cytoskeleton.
Comparison of phenotypes associated with abpl and rvsl67 mutations strongly suggests that the functions of the two proteins are closely related. Abpl mutant defects in sporulation and cell viability in poor growth media are similar to, although milder than, defects reported for rvsl67 mutations ( Figure 8A ; Table 2 ). Abpl and rvsl67 null mutations show similar profiles of genetic synthetic-lethal interactions with genes encoding components of the cortical cytoskeleton (Figure 8C) , and the deleterious effects of Abplp overexpression are ameliorated by deletion of RVS167 ( Figure 8B ). These observations are consistent with a model in which binding to Abplp modifies the activity of Rvs167p, perhaps by influencing the subcellular localization of Rvs167p or by influencing the association of Rvs167p with actin and/or other cellular factors.
Rvs167p shows sequence similarity with human amphiphysin (David et al., 1994; Sivadon et al., 1995) .
Amphiphysin has been proposed to function in endocytosis of synaptic vesicles, and mutations in RVS167 have been shown to affect fluid phase endocytosis in yeast (Munn et al., 1995) . The SH3 domain of amphiphysin has been shown to be capable of binding to dynamin and to synaptojanin, two proteins also thought to play roles in synaptic vesicle recycling McPherson et al., 1996) . By analogy, the Rvs167p SH3 domain might also bind to ligands having functions in endocytosis. The yeast dynamin homologues Vpslp/Spol5p and Dnmlp do not contain sequence motifs similar to known SH3 domainbinding sites (Yeh et al., 1991; Gammie et al., 1995) , however, suggesting that they do not physically interact with the Rvs167p SH3 domain. One possibility then is that Abplp has a function in endocytosis. ABP1 mutation does not dramatically affect the uptake of extracellular a factor (Kubler and Riezman, 1993 (Amberg et al., 1995) . Direct binding of the two proteins has not been demonstrated, and it is not known whether monomeric or filamentous actin is the relevant binding partner.
An N-terminal 180-amino acid fragment of Abplp binds to filamentous actin in vitro (Chamany and Drubin, unpublished results) and has sequence similarity to proteins of the ADF/cofilin family (reviewed in Moon and Drubin, 1995) , Dictyostelium coactosin (de Hostos et al., 1993) , and an N-terminal domain of the vertebrate neuronal actin-binding protein drebrin (23% amino acid identity with rat drebrin A over a 130-amino acid span; see MATERIALS AND METH-ODS). Cofilins can sever actin filaments while coactosin and drebrin do not; therefore, these evolutionarily related proteins clearly do not all function in a precisely analogous manner, but a common theme may lie in the roles of these proteins as stimulus-responsive Vol. 8, February 1997 modulators of actin filament architecture and dynamics. A large body of evidence links changes in the activity of cofilin, for example, to cytoskeletal rearrangements which occur in response to receptor stimulation in cells such as platelets and T-cells (Moon and Drubin, 1995) . Marked changes in the association of drebrin with cellular actin-containing structures accompanies the retinoic acid-induced differentiation of neuroblastoma cells (Asada et al., 1994) , and expression of drebrin in non-neuronal cell types leads to the formation of neurite-like outgrowths (Shirao et al., 1992) . Like cofilin and drebrin, Abplp may exert effects on actin filament architecture in response to stimulation of signal transduction pathways by extracellular cues. This possibility is consistent with the abpl mutant phenotypes reported here and with evidence for the indirect association of Abplp with adenylyl cyclase via Srv2p (see below).
Srv2p immunolocalization experiments provide strong evidence that the Abplp SH3 domain mediates the association of Srv2p with cortical actin patches in vivo (Figures 2, 3C , and 6). Although (Figures 4-7) . We also identify genetic backgrounds in which Srv2p is essential for viability ( Figure 6 ) and show that neither of the proposed SH3 domain-binding sites in Srv2p (Freeman et al., 1996) are required in those backgrounds (Figure 7 ). Srv2p homologues in other species, like yeast Srv2p, associate with cortical actin-containing structures (Vojtek and Cooper, 1993; Gottwald et al., 1996) , but at the present time we can only speculate as to what the precise function of this association may be.
Srv2p binds to adenylyl cyclase in vivo and has a role in generating the abnormally high intracellular cAMP levels associated with mutational activation of Ras2p. However, its role in normal RAS/adenylyl cyclase pathway signaling has yet to be elucidated (Fedor-Chaiken et al., 1990; Wang et al., 1992 Wang et al., , 1993 . cAMP-dependent protein kinase-mediated signals are required for growth and cell cycle progression past the unbudded (G1) stage in S. cerevisiae, and recent reports have suggested that cAMP-mediated events can also delay the timing of bud emergence by exerting a negative effect on G1 cyclin synthesis (Broach, 1991; Baroni et al., 1994; Tokiwa et al., 1994) . Although changes in actin organization which underlie bud emergence are controlled by changes in cyclin-dependent kinase activity (Lew and Reed, 1993) , it is also possible that the Ras proteins and downstream effectors provide additional regulatory inputs into the cytoskeletal and/or secretory functions responsible for cell surface growth. In nerve synaptic termini, changes in the phosphorylation states of vesicle-associated proteins have been proposed to regulate a number of processes required for neurotransmitter exocytosis, including dissociation of vesicles from the actin cytoskeleton, vesicle-plasma membrane docking, and vesicle-plasma membrane fusion (reviewed in Greengard et al., 1993) . One possibility in budding yeast is that Abplp and Srv2p, through interaction with adenylyl cyclase, affect the local activity of cAMP-dependent protein kinases and thus assist in the regulation of functionally similar phosphorylation events that influence vesicle delivery or fusion at the bud site. A role for Srv2p in influencing secretory processes is consistent with the observation that overexpression of SNC1, which encodes a homologue of the synaptic vesicle-associated protein synaptobrevin, partially suppresses defects associated with an srv2 mutation (Gerst et al., 1992) .
Although our results demonstrate that binding of the Abplp SH3 domain to Srv2p is not required for the viability of ABPI-dependent strains (Figure 7) , an Abplp SH3 domain having a ligand specificity similar to wild type is apparently required in these backgrounds. Since all functional versions of Abplp contain SH3 domains capable of binding to the Srv2p sequence KSGPPPRPKK (Figures 3B, 4A , and 4C), one possibility is that the Abplp SH3 domain binds to a ligand in addition to Srv2p containing a similar sequence. Candidates include a protein implicated in bipolar bud site selection, Bud8p (Zahner et al., 1996) , predicted to contain the sequence KNGTPPRPTS (GenBank accession number L37016), and a hypothetical ankyrin repeat-containing protein containing the sequence KTTPPPAPRS (GenBank accession number L28920). The possibility that Abplp binds to Bud8p is intriguing in light of the fact that Abplp overproduction causes haploid cells, which normally bud in an axial pattern, to adopt the bipolar budding pattern characteristic of diploids.
In our examination of the phenotypes of a new srv2 deletion mutant, we find one significant difference from previous characterizations. The srv2A2 mutation does not result in inviability on rich media ( Figure  3A ). Our motivation for generating a new srv2 deletion allele stemmed from the curious behavior of the preexisting deletion under certain conditions we examined. Either in the original strain background or when outcrossed to the SC288 background four times, strains carrying the srv2 deletion, but also carrying any of several independently isolated genomic DNA fragments carrying SRV2+ on a plasmid, were unable to grow on glycerol-containing medium. Strains carrying the srv2A2 mutation and one of the SRV2+ plasmids grow as well as the wild type on this medium. We speculate that the strain isolate carrying the original deletion that we used may carry an additional mutation in a gene linked to SRV2, or that the effect described may be due to expression of a small Nterminal region of Srv2p which is left intact by the deletion.
Despite the fact that ABP1 is dispensable for the growth of yeast in the laboratory, work presented here demonstrates that it participates in a complex set of interactions which become important for cell survival when environmental stresses are introduced. Evidence for the physical and functional association of Abplp with Rvsl67p and Srv2p suggests that endocytosis, actin assembly, and adenylyl cyclase signaling are coordinated to maximize cell fitness and adaptability.
